{"name":"Institut de Recherche en Sciences de la Sante, Burkina Faso","slug":"institut-de-recherche-en-sciences-de-la-sante-burkina-faso","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amodiaquine Sulfadoxine-Pyrimethamin administration","genericName":"Amodiaquine Sulfadoxine-Pyrimethamin administration","slug":"amodiaquine-sulfadoxine-pyrimethamin-administration","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Amodiaquine Sulfadoxine-Pyrimethamin administration","genericName":"Amodiaquine Sulfadoxine-Pyrimethamin administration","slug":"amodiaquine-sulfadoxine-pyrimethamin-administration","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1EZlhsMkIwTksxVTVsaDBEZ3FDOTJyMnl2T0R2X2cteFhOQW5JQkZBLS1qd3hXLS1wUVotY3g5Z2tsZHVyZ0dVSjVkRmF0VkJqaXpDWEpTOVNwcWlqQUZj?oc=5","date":"2025-02-06","type":"pipeline","source":"nature.com","summary":"The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 - nature.com","headline":"The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DMFpQeGRJOEhnWk1PaGZWVFJNSWFCLTVhVW5felhlRDFiaVZCSWlHUUVpekI1WGpYc2xiZ19TTklHbGZQN21fcmN6aVNXVms1dEtvby1NSVRTeEJOWjhV?oc=5","date":"2025-01-16","type":"pipeline","source":"nature.com","summary":"Transmission of transgenic mosquito-killing fungi during copulation - Scientific Reports - nature.com","headline":"Transmission of transgenic mosquito-killing fungi during copulation - Scientific Reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQWVlSZGFzNDVTTzgyYjBYX2Jpd2U5eHdNOUppQ1NJOWpDVzJ4RGVTS1NnZnh3ZWhMUXdMazV2YW5vaWVjS2xpRUsxeFMydW1VcGdQWnlHUkJzWE9feWVrWW1rTU0xZEV2QkhXTUFsbzB6UWdwM2JCR3I3VnhFYjRVejZvU3ZvVUt4Q1Bj?oc=5","date":"2024-12-10","type":"trial","source":"The Lancet","summary":"Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children - The Lancet","headline":"Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBTeXFlcVF5cFRSTUdJVjZ0SVAzeTBlTWtoUWFmV19Ud21nSkdycXF1cFQ1LVdfUU82NlJMXzZxMlV3dkYxR0F5NF9jcXM1X2RqX3hTR1pESVQ2dC1KTGJkRjVLenBNV0xGSUV4U1RWbTlWa2I0QVQ5d1J6WQ?oc=5","date":"2023-08-04","type":"pipeline","source":"pharmaphorum","summary":"GSK scientists find new way to fight malaria - pharmaphorum","headline":"GSK scientists find new way to fight malaria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPTmthblNzTGFMbHpzY0tscFBYdEwyMUozUkIyM3BjN251NW5IaHhqWndRUmRQN0k3ZVBPdTNPck5KX2JCenFtNXQ1Wk1qbHhvRFd0ZkU0QW1BelhPbHZ1SkRtdVBjUVEwVUdjdTBndnRLOS1qemk0UTQ0VzdzRTY0YXUydVRySjdZbWtScW8yc0lzanBCQzk4QWprSlRDMXg2Z2NXYVE5b2lWdU51c0RJ?oc=5","date":"2023-07-27","type":"pipeline","source":"Anadolu Ajansı","summary":"Burkina Faso : plus de 4 mille décès dus au paludisme en 2022 - Anadolu Ajansı","headline":"Burkina Faso : plus de 4 mille décès dus au paludisme en 2022 - Anadolu Ajansı","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPMjlsNEtncXV3UTJjZEQ5TW16aXNMeVdzR0dKd1JvaTFJMXAyeGdjbHAwclExZFIzdjBCalBVT1E5Zjh0UzRDTG93cWpuQ1k2aXF3VTI2VTk2T3o1ZmlJcGlwQ1AtaFVNVDNySGU0TGR3MWxoMFBiTk1BMjJLVTc5VXdZYnctb09G?oc=5","date":"2022-09-07","type":"trial","source":"The Lancet","summary":"Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial - The Lancet","headline":"Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Bur","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-09-02","type":"trial","source":"Medical Dialogues","summary":"Malaria vaccine and antimalarial drugs combo may reduce malaria deaths in kids by 73%: Study - Medical Dialogues","headline":"Malaria vaccine and antimalarial drugs combo may reduce malaria deaths in kids by 73%: Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNWWNtdEdCSHE3c2pWdkJRczU1WW0zVFFQaHlEVVdsMzYzd2JSd0t0aDMzU2tTak5mYmw5YkJTdnVkekhBLUV5dlQ2U2hxYVo4UVAyUmFBYkZ2dWowUERGQ2p2SzJWZGVyNXlJbTI0MFdsUG1KWGFtbjVGN3lMaHEwOFVVMnZKNWFXcGNJM1BEYXgxODlUdlJJSTZuS2FaRENIVzZnQ1RVMlZzbDRyTGhtcDZNX1BSbTAtdUVFNUhQVjZWWmtSV2o1UEYwb0Fla3JubENDSzMwOV8yclJ5VjRFa1g3LVVaZmgzSU1KU2k2bkJ5N3NBZndlNA?oc=5","date":"2021-06-03","type":"pipeline","source":"2 Minute Medicine","summary":"VisualAbstract: Novel malaria vaccine candidate (R21/MM) is safe and highly protective against malaria transmission in African children - 2 Minute Medicine","headline":"VisualAbstract: Novel malaria vaccine candidate (R21/MM) is safe and highly protective against malaria transmission in A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSzc4cm5qWkhSdFg3a2t0UUg3NDZ2QzNBdkdxWmUwX2RiN0xQbGZlYzRZWmNJV2cwbkFHQndRcHhMU1RWaUw5LW1IZEVPb3NDa1QyVDFpMV9nTi00MThodUVDTFRZWV9fNktkYVlQeGhqTWxPd01IaGhpSThKX0JCYVpnY3Itamw5WkdZ?oc=5","date":"2021-05-05","type":"trial","source":"The Lancet","summary":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial - The Lancet","headline":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9rT1RZcDc5emlLdGpjWmxtd0JMSURzcUpRbVFTRWdqelp3VldYM1VQMkxkQ0JRRXpoN2d1ZTFKVnNWcVc5YVloV0dEUDdkUDg4elItd3JQWnZBWkRMVTc0?oc=5","date":"2018-04-11","type":"pipeline","source":"nature.com","summary":"Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity - nature.com","headline":"Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}